Article
Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism.
Biological psychiatry - 15 Feb 2009
Lotrich Francis E, Ferrell Robert E, Rabinovitz Mordechai, Pollock Bruce G
Abstract excerpt
BACKGROUND: Major depressive disorder (MDD) occurs in a subset of patients receiving interferon-alpha treatment, although many are resilient to this side effect. Genetic differences in the serotonin reuptake transporter promoter (5-HTTLPR) may interact with the inflammatory system and influence d...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
